Radioimmunotherapy as a novel treatment regimen: 125I-labeled monoclonal antibody 425 in the treatment of high-grade brain gliomas.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001254:Astrocytoma / Q000532:radiotherapy* / Q000601:surgery; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005500:Follow-Up Studies; D005909:Glioblastoma / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D016499:Radioimmunotherapy / Q000379:methods*; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes; D066246:ErbB Receptors